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Objective: Our previous study described the increasing adoption of uterine-preserving procedures in the
surgical approach for uterine prolapse. In this follow-up study, we further explored the reoperation rate
and variables for the choice of surgeries after primary uterine prolapse surgery, based on the nationwide
claim data in Taiwan.
Materials and methods: The data of this study was obtained from the Inpatient Expenditures by
Admission ﬁles of the National Health Insurance Research Database (NHIRD). Women who received
primary and repeat surgeries, either hysteropexy or hysterectomy, were identiﬁed between 1997 and
2010; and followed up to 2010 or till the event of reoperation. We analyzed the variables including the
primary surgical type, concomitant stress urinary incontinence (SUI) surgery, patient age, surgeon age,
and hospital accreditation level.
Results: Among the total 36,609 women, a higher reoperation rate was noted in the hysteropexy group
(156/4095) (3.81%) than in the hysterectomy group (116/32,514) (0.36%); the adjusted odds ratio (OR)
was 11.70 [95% conﬁdence interval (CI): 8.86e15.43]. It was lower in patients with concomitant SUI
surgery; older patients (aged  60 years and 40e69 years vs. < 40 years); older surgeons (aged  50
years and 40e49 years vs. < 40 years), but not signiﬁcant in hospital levels. Hysterectomy was the
preferred choice as compared with repeat hysteropexy (69.87% vs. 30.13%) among the failed hysteropexy
group. All variables for the choice of repeat hysteropexy were not signiﬁcant.
Conclusion: Our study offers a population-based nationwide observation that hysteropexy correlates
with a higher reoperation rate, as compared with hysterectomy; but it is still as high as 30% in the
surgical choice of the failed hysteropexy group.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Uterine prolapse, an apical defect of pelvic organ prolapse (POP),
is a commonly encountered women's health issue with a negative
impact on a patient's quality of life.1 The lifetime risk of undergoing
prolapse or continence surgery is 11.1%,2 which increases as the life
expectancy increases. The number of surgeries for urinary incon-
tinence and POP will increase substantially over the next 40 yearsre no conﬂicts of interest.
s and Gynecology, Chi Mei
d, Yung Kang, Tainan, 710,
Wu).
for Gynecologic Endoscopy and Minimaccording to a forecasting study.3 Traditionally, repair of POP with a
concomitant hysterectomy is considered the “standard of care” for
uterovaginal prolapse. As early as 1934, Bonney4 suggested that
descent of the uterus is the consequence, and not the cause, of
uterine prolapse. The pathological cause of uterine prolapse is loss
of integrity of the uterosacral and cardinal ligament complex and a
weakening of the pelvic ﬂoor diaphragm.5 Uterine prolapse can
result from any defect of the following: the constriction of the
bottomof the vagina, the suspension of the uterosacral and cardinal
ligament, and ﬂap valve closure against the pelvic wall; hence,
removing the uterus to treat POP does not appear logical.4 There-
fore, whether hysterectomy remains as the “standard of care” in
modern gynecologic practice remains debatable. Moreover, womenally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
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maintain future fertility, the belief that the uterus affects sexual
function or sense of identity, an increase in conservative treatment
for menorrhagia, concern about the risks of hysterectomy, and the
length of recuperation.6
Our previous study described the changing trends of surgical
approaches for POP in Taiwan, and presented an account of the
increasing use of hysteropexy with uterine preservation during
recent years.7 Although POP is often considered a condition of the
elderly, a national census and survey in the United States reported
the surgical distribution rates according to age group: prolapse
surgical rates (per 10,000 women) were seven, 24, 31, and 17 in
reproductive age, perimenopausal, postmenopausal, and elderly
age groups, respectively.8 It suggests that POP is a condition
affecting women across the reproductive life cycle and for which
women of all ages seek surgical treatment. In recent years, interest
in uterine preservation has been growing worldwide. According to
a recent multicenter, cross-sectional study, a higher proportion of
women with symptomatic prolapse preferred to retain the uterus
at the time of surgery in the absence of a substantial beneﬁt of
hysterectomy.9 Today, more uterus-preserving procedures are used
to treat POP; uterine preservation is now feasible during pelvic
reconstructive surgeries.10,11 After our initial observation of an
increasing use of hysteropexy with uterine preservation in treating
uterine prolapse, we further explored the reoperation rates and the
variables of surgical type, either hysterectomy or hysteropexy, for
the failed primary surgery for uterine prolapse; also, we tried to
identify the variables of the choices of repeat hysteropexy among




The data used in this study were obtained from the National
Health Insurance Research Database (NHIRD). The NHIRD was
established by the National Health Research Institute, in coopera-
tionwith the NHI Bureau, with the aim of undertaking research into
current and emerging issues in Taiwan. The details of the NHIRD
were described in our previous report.7 Brieﬂy, NHIRD offered the
information of NHI-reimbursed hospital discharges on inpatient
characteristics, the dates of admission and discharge, the type of
disease, and the surgery code (based upon the International Clas-
siﬁcation of Diseases, 9th Revision, Clinical Modiﬁcation, ICD-9-
CM). Anonymous identiﬁers of the medical institutions and phy-
sicians were used to link the hospital discharge data to the physi-
cian and hospital registries. Conﬁdentiality assurances were
ensured abiding by data regulations of the NHI Bureau. We con-
sulted with the Institutional Review Board of Chi Mei Foundation
Hospital, Tainan, Taiwan and obtained a formal written waiver for
the need of ethics approval (No. 10202-E08).
Study participants
Study participants were women who had NHI and received
primary surgeries, either hysteropexy with uterine preservation, or
hysterectomy with/without colpopexy, due to the diagnosis of
uterine prolapse in Taiwan between January 1, 1997 and December
31, 2010. A diagnosis of uterine prolapse included ICD-9 CM diag-
nosis codes 618.1 for uterine prolapse without mention of vaginal
wall prolapse; 618.2 for uterovaginal prolapse, incomplete; 618.3
for uterovaginal prolapse, complete; and 618.4 for uterovaginal
prolapse, unspeciﬁed, but not vaginal vault prolapse (618.5 pro-
lapse of the vaginal vault after a hysterectomy). The surgicalapproaches received by the women for uterine prolapse were
categorized as follows: (1) hysteropexy with uterine preservation
(hysteropexy group): ICD-9 CM operation code 69.22 for other
uterine suspension, including a hysteropexy, Manchester operation,
and plication of uterine ligament; and (2) hysterectomy with/
without colpopexy (hysterectomy group): ICD-9 CM operation code
70.77 for vaginal suspension and ﬁxation. A concomitant hyster-
ectomy included any of the following: a subtotal (supracervical)
abdominal hysterectomy (SAH; 68.3); a total abdominal hysterec-
tomy (TAH; 68.4); laparoscopic hysterectomy (LH; 68.51, or 68.5
vaginal hysterectomy with 54.21 laparoscopy); and a vaginal hys-
terectomy (VH; 68.59, or 68.5 vaginal hysterectomy without 54.21
laparoscopy). A concomitant stress urinary incontinence (SUI)
surgery was described as plication of the urethra-vesical junction,
e.g., a Kelly-Kennedy operation (59.3); a suprapubic sling operation,
e.g., Goebel-Frangenheim-Stoeck suspension (59.4); retropubic
urethral suspension, e.g., a Marshall-Marchetti-Kranz (MMK)
operation, Burch procedure (59.5); paraurethral suspension (nee-
dle suspension), e.g., Pereyra suspension (59.6); injection of an
implant into the urethral and/or bladder neck, e.g., collagen
implant (59.72); and others (59.79), e.g., abdominal perineal ure-
thral suspension (APUS), midurethral sling, etc.
Thereafter, we followed these women until the event of reop-
eration after failed primary surgery or the end of 2010. The women
receiving repeat surgeries after failed primary surgery for a uterine
prolapse were further categorized into either repeat hysteropexy or
hysterectomy as a treatment modality; while colpopexy (vaginal
suspension) was the only treatment of the failed hysterectomy
group. The failure (reoperation) rate was deﬁned as the proportion
of repeat surgery (i.e. failed surgeries and need repeat surgery),
over primary surgery.
Variable deﬁnitions
We identiﬁed the variables including primary surgical type,
concomitant SUI surgery, patient age, surgeon age, surgeon gender,
and hospital accreditation level. The variables used in this study fell
into the following categories: (1) primary surgical type, either
hysterectomywith/without colpopexy, or hysteropexy with uterine
preservation; (2) concomitant SUI surgery; (3) patient age, which
was divided into three age groups, i.e., < 40 years, 40e59 years, and
 60 years of age; (4) surgeon characteristics (age and gender), the
surgeon's age was divided into three groups, < 40 years, 40e49
years, and  50 years; and (4) hospital accreditation levels, the
hospitals are accredited by the Taiwan Joint Commission on Hos-
pital Accreditation (TJCHA) which is supervised by the Department
of Health, Executive Yuan (Taiwan), and classiﬁed into three levels
(medical centers, regional hospitals, and local hospitals) based on
health care quality, medical teaching ability, clinical capabilities,
and bed capacity.7
Statistical analysis
Chi-square tests were performed to examine differences in the
repeat surgery distribution of the two types of surgeries. The Stu-
dent t test was performed to examine the interval between the
primary and repeat surgery of the two types of surgeries, hyster-
ectomy or hysteropexy. A crude and multiple logistic regression
were used to examine the independent effects of each individual
variable for the failed surgeries for uterine prolapse, i.e., primary
surgical type (hysteropexy or hysterectomy), concomitant SUI
surgery, patient age, surgeon age and gender, and hospital
accreditation level. The comparison of variables of the choices of
repeat hysteropexy among the failed hysteropexy group was also
performed. The signiﬁcance of the statistics was determined using
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system software (SAS Institute, Cary, NC, U.S.A.) for Windows
(version 9.3.1).
Results
In total, 36,609 women received the primary surgeries for
uterine prolapse were identiﬁed. Of them, 32,514 (88.8%) received
the hysterectomy with/without colpopexy (hysterectomy group);
while 4095 of them (11.2%) received hysteropexy with uterine
preservation (hysteropexy group). During the study period, these
women were followed till the event of reoperation after failed
primary surgery or the end of 2010, with a mean interval of
97.64 ± 83.04 months (Table 1). A higher reoperation (failure) rate
was noted in the hysteropexy group, 3.81% (156/4095) vs. 0.36%
(116/32,514), p < 0.0001; and a borderline shorter interval till
reoperation, 94.15 ± 80.08 months vs. 115.6 ± 97.12 months,
p ¼ 0.0533, as compared with the hysterectomy group (Table 1).
After the failed primary surgery, colpopexy (vaginal vault sus-
pension) was done in the entire hysterectomy group. The choices of
repeat surgery among the failed hysteropexy group were either
hysterectomy (109/156) (69.87%) or repeat hysteropexy (52/156)
(33.33%). Hysterectomy remains the main surgery up to two thirds
for repeat surgery for uterine prolapse, which is even higher than
that in primary surgery (47/156) (30.13%) (Fig. 1).
The comparison of variables for the failed primary surgeries for
uterine prolapse is shown in Table 2. The odds ratio (OR) for
reoperation was higher in the hysteropexy group than in the hys-
terectomy group [adjusted OR: 11.70, 95% conﬁdence interval (CI):
8.86e15.43]. The reoperation rate was lower in patients with
concomitant SUI surgery (adjusted OR: 0.62, 95% CI: 0.43e0.90).
As for patient age, the reoperation was lower in the > 60 years
and 40e59 years age groups as compared with the < 40 years age
group; crude ORs 0.31 and 0.19 (95% CI: 0.22e0.42 and 0.14e0.26,
respectively); however, the adjusted OR became non-
signiﬁcantdadjusted OR 0.91 (95% CI: 0.65e1.28) and 0.79 (95% CI:
0.54e1.15), respectively. The reoperation was lower in womenwith
concomitant SUI surgery, adjusted OR 0.62 (95% CI: 0.43e0.90).
Reoperation was signiﬁcantly lower in the surgeon age group 50
years and 40e49 years as compared with the < 40 years age group;
adjusted OR 0.70 (95% CI: 0.52e0.93) and 0.71 (95% CI: 0.51e0.98),
respectively. The hospital accreditation level was not signiﬁcant.
Among the choice of repeat hysteropexy after failed primary
surgery among the hysteropexy group, hysterectomy (109/156) was
the preferred choice, as compared with repeat hysteropexy (47/
156), 69.87% and 30.13.7%, respectively. Though hysterectomy re-
mains the main surgical type for repeat surgery for uterine pro-
lapse, hysteropexy remains up to 30%, which is even higher than
that in primary surgery (11.19%) (Fig. 1). The variables for adopting
hysteropexy as repeat uterine prolapse surgery were shown in
(Table 3). These variables were not signiﬁcant, including concom-
itant SUI surgery, patient age, surgeon age, and hospital accredi-
tation level (Table 3).Table 1






No. (%) No. (%) (mons)
Hysterectomy 32,514 88.81 116 0.36 <0.0001 115.6 ± 97.12 0.0533
Hysteropexy 4,095 11.19 156 3.81 94.15 ± 80.08
Total 36,609 100.00 272 0.84 97.64 ± 83.04
Note: Repeat surgery was deﬁned as failed primary surgeries and need repeat
surgery.Discussion
Our study offers a population-based nationwide observation
that the primary surgical type, either hysteropexy or hysterectomy,
correlates with the reoperation (failure) rate which was deﬁned as
failed-primary-need-repeat surgery, after primary surgeries for
uterine prolapse. Hysteropexy has a higher reoperation rate, 3.81%
vs. 0.36% with an adjusted OR as high as 11.7, as compared with
hysterectomy. It is in concordance with the report of Rosen et al,12
in which preserved uterus (21.4%) during laparoscopic pelvic ﬂoor
repair has a higher recurrent prolapse, as compared with the hys-
terectomy group (12.9%). However, hysteropexy still accounts as
high as 30% in the choice of repeat surgery in the failed hysteropexy
group, which was even higher than that of primary surgery
(11.19%). This implies that patients, as well as surgeons, desire the
uterine-preserving procedures in treating uterine prolapse.
Reoperation remains the main problem in treating POP. It was
reported in as high as 29.2% of patients, and the time intervals
between repeat procedures decreased with each successive repair.2
In our study, a relative low reoperation (failure) rate, was noted
after primary surgery for uterine prolapse, with 0.84% for overall,
3.81% for the hysteropexy group, and 0.36% for the hysterectomy
group, which is much lower than that in Olsen et al. report.2 It is
obvious that our report underestimates the surgical failure rate,
because of the assumption that failed primary surgeries need
repeat surgery equal to the failure after primary surgery. It is highly
possible that many women may choose nonsurgical conservative
treatment afterwards.13 Patel et al14 reported an improvement of
prolapse-related quality of life and perception of body image in
questionnaires of pessary use during 6 months (p < 0.001) and 12
months (p < 0.010) follow-up, but not in younger women and those
with prior prolapse surgery. Although pessaries can treat symp-
toms in most women, the patient will require lifetime care of the
pessary including regular cleaning and replacement.15 Surgery is an
effective treatment but has operative morbidity and a recurrence
rate. To assess whether patients prefer surgery or a pessary as
treatment for pelvic organ prolapse, Thys et al13 reported that pa-
tients switched preference from pessary to surgery at a median risk
of vaginal irritation of 32%, of placing problems of 32%, and of
incomplete symptom relief of 17%. Patients tend to prefer surgery
when realistic assumptions for advantages and disadvantages are
made.13
Hysterectomy remains the main surgery for primary uterine
prolapse surgery (88.81%), as well as repeat (69.87%) surgery
among the failed hysteropexy group. Nevertheless, hysterectomy
remains as the “standard of care” in treating POP, because of the
understanding that the uterus is believed to be a passive structure
in the disease process.4,5 Therefore, more reﬁned and effective
procedures are mandatory and indispensable.15 Recently, more and
more novel surgical approaches make uterine preservation more
feasible during pelvic reconstructive surgery.10,11 Several surgical
approaches have been developed via the routes of vaginal,
abdominal, laparoscopic, or robotic-assisted procedures, e.g., sacral
hysteropexy,16 uterosacral hysteropexy,17 sacrospinous hyster-
opexy,18 and vaginal mesh hysteropexy.19,20 In the Gutman and
Maher6 review, sacrospinous hysteropexy (87%, 373/428) is as
effective as vaginal hysterectomy and repair (93%, 242/262) in
retrospective comparative studies and in a meta-analysis with
reduced operating time, blood loss, and recovery time. However, in
a single randomized control trial therewas a higher recurrence rate
associated with sacrospinous hysteropexy compared with vaginal
hysterectomy (21% vs. 3%).21
Meanwhile, with the widespread use of synthetic mesh via
vagina, open laparotomy, laparoscopy,22 or robotic assisted sacro-
colpopexy23 for the pelvic reconstructive surgery, uterine-
Fig. 1. The choice of hysteropexy or hysterectomy as primary surgery, and repeat surgery after failed primary uterine prolapse surgery.
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Sacrospinous hysteropexy with mesh augmentation of the ante-
rior compartment was as effective as hysterectomy and mesh
augmentation with no signiﬁcant difference in the rate of mesh
exposure between the groups.6 Sacral hysteropexy (open or
laparoscopic) was as effective as sacral colpopexy and hysterec-
tomy in anatomical outcomes; moreover, performing hysterec-
tomy at sacral colpopexy was associated with a four times higher
risk of mesh exposure compared with no-hysterectomy.6 There-
fore, uterine preservation is a viable option for the surgical
management of uterine prolapse, but the evidence on safety and
efﬁcacy is currently lacking. Jeon et al24 further points to the use
of a graft, rather than hysterectomy, as being necessary for the
pelvic reconstructive surgery for uterine prolapse. Whether we
expect hysteropexy to fare better than hysterectomy and become
the surgical “gold standard” of the future needs further
elucidation.25
A recent systemic review about robotic-assisted sacrocolpopexy
from 27 included articles, with total 1488 surgeries, from 2006 to
2013, reported that the objective and subjective cures ranged from
84% to 100% and from 92% to 95%, respectively. Conversion rate toTable 2
The comparison of variables for the failed-primary-need-repeat surgery for uterine prola
Primary surgery Repeat surgery
No. % No. %
Primary surgical type Hysterectomy 32,514 88.81 116 0.36
Hysteropexy 4,095 11.19 156 3.81
SUI surgery No 31,467 85.95 235 0.75
Yes 5,142 14.05 37 0.72
Patient age <40 2,282 6.23 58 2.54
40e59 14,706 40.17 117 0.80
60 19,621 53.60 97 0.49
Surgeon age <40 9,256 25.28 90 0.97
40e49 17,011 46.47 116 0.68
50 10,342 28.25 66 0.64
Surgeons gender Female 3,362 9.18 29 0.86
Male 33,247 90.82 243 0.73
Hospital level Medical center 17,289 47.23 126 0.73
Regional 13,279 36.27 107 0.81
Local 6,041 16.50 39 0.65
Total 36,609 100 272 0.74
Note: Repeat surgery was deﬁned as failed surgeries and need repeat surgery.
*p-value <0.05.open surgery was < 1% (range: 0e5%). It is more costly than the
laparoscopic procedure. Robotic-assisted sacrocolpopexy is a safe
and feasible prolapse repair procedure; it allows the execution of
complex surgical steps via minimally invasive surgery without
medium- and long-term anatomic detriments.23 As for transvaginal
mesh kits, a recent systemic review by Feiner et al19 from 30
included studies, a total of 2653 women, reported the objective
success rates of two commercial transvaginal mesh kits were either
95% (95% CI 95e96%) or 87% (95% CI 86e87%), respectively. Reop-
erations not requiring anesthesia occurred in 0.4e2.3% and
requiring anesthesia in 1.5e6.0%, with a follow-up between 26
weeks and 78 weeks. Mesh erosion was the most commonly re-
ported complication occurring in 4.6e10.7%.19 The overall objective
success using transvaginal mesh kits in restoring apical vaginal
prolapse is high. However, an increasing number of women require
surgical intervention for mesh-related complications based on
limited data quality and short follow-up.19
There were several variables noted for reoperation for the failed
primary surgeries. Elderly women had a lower reoperation rate (in
the crude OR), as compared with younger patients; which implies
that the elder patients opted to choose more conservativepse.
No-repeat surgery Crude OR (95% CI) Adjusted OR (95% CI)
No. %
32,398 99.64 1.00 1.00
3,939 96.19 11.06* (8.68e14.10) 11.70* (8.86e15.43)
31,232 99.25 1.00 1.00
5,105 99.28 0.96 (0.68e1.37) 0.62* (0.43e0.90)
2,224 97.46 1.00 1.00
14,589 99.20 0.31* (0.22e0.42) 0.91 (0.65e1.28)
19,524 99.51 0.19* (0.14e0.26) 0.79 (0.54e1.15)
9,166 99.03 1.00 1.00
16,895 99.32 0.70* (0.53e0.92) 0.70* (0.52e0.93)
10,276 99.36 0.65* (0.48e0.90) 0.71* (0.51e0.98)
3,333 99.14 1.00 1.00
33,004 99.27 0.85 (0.58e1.25) 0.71 (0.47e1.06)
17,163 99.27 1.00 1.00
13,172 99.19 1.11 (0.85e1.43) 1.01 (0.77e1.32)
6,002 99.35 0.89 (0.62e1.27) 0.89 (0.60e1.31)
36,337 99.26
Table 3
The comparison of variables of the choices of repeat hysteropexy among the failed hysteropexy group.
Hysteropexy gr. Re-hysteropexy Hysterectomy Crude OR (95% CI) Adjusted OR (95% CI)
No. % No. % No. %
SUI surgery No 133 85.26 42 31.58 91 68.42 1.00 1.00
Yes 23 14.74 5 21.74 18 78.26 0.60 (0.21e1.73) 0.67 (0.22e2.09)
Patient age <40 57 36.54 22 38.60 35 61.4 1.00 1.00
40e59 63 40.38 17 26.98 46 73.02 0.59 (0.27e1.27) 0.57 (0.25e1.28)
60 36 23.08 8 22.22 28 77.78 0.46 (0.18e1.18) 0.37 (0.13e1.04)
Surgeon age <40 46 29.49 14 30.43 32 69.57 1.00 1.00
40e49 79 50.64 21 26.58 58 73.42 0.83 (0.37e1.85) 0.93 (0.40e2.18)
50 31 19.87 12 38.71 19 61.29 1.44 (0.55e3.76) 1.60 (0.55e4.60)
Surgeons gender Female 11 7.05 2 18.18 9 81.82 1.00 1.00
Male 145 92.95 45 31.03 100 68.97 2.03 (0.42e9.75) 1.71 (0.33e8.99)
Hospital levela Medical center 68 43.87 16 23.53 52 76.47 1.00 1.00
Regional 68 43.87 21 30.88 47 69.12 1.37 (0.65e2.90) 1.23 (0.56e2.73)
Local 19 12.26 9 47.37 10 52.63 2.75 (0.96e7.90) 2.58 (0.80e8.29)
Total 156 100 47 30.13 109 69.87
Note: Repeat surgery was deﬁned as failed surgeries and need repeat surgery.
*p-value <0.05.
a One case was not available for missing hospital level information, n ¼ 46 in this category.
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younger patients. As for patient preference, Korbly et al9 reported
that if uterine preservation was superior, 46% of the women
preferred uterine preservation and 11% of the women preferred
hysterectomy. If hysterectomy was superior, 21% of the women still
preferred uterine preservation, despite inferior efﬁcacy.9 Other
factors, e.g., college education (OR 2.87; 95% CI 1.08e7.62) and
those who believed that the uterus is important for their sense of
self (OR 28.2; 95% CI 5.00e158.7) had increased odds for preferring
uterine preservation.9
As for patient preoperative condition, advanced pelvic organ
prolapse correlates with a higher risk of recurrent prolapse after
sacrospinous hysteropexy.6,26 The surgical failure of hysteropexy
could be explained by cervical elongation.12,27 Berger et al24
showed that one third of women with POP had cervical elonga-
tion, and the extent of elongation increases with greater degrees of
uterine descent. Cervical elongation is more likely to occur in young
and premenopausal patients, and cervical and uterine corpus
length decreases as women progress past the menopausal transi-
tion.24 Thereafter, preoperative cervical elongation is a relative
contraindication for uterine preservation, and a long cervix may
compromise patient satisfaction after a hysteropexy.24,25 Because of
the inherent limitation of our data source, we did not know if
cervical elongation affected the surgical decision for uterine pro-
lapse; neither can we distinguish the effect of cervical elongation
on the repeat surgery.
One interesting phenomenon is that women with concomitant
SUI surgery had a lower reoperation rate. It is more likely that these
surgeries were performed by surgeons of urogynecology sub-
specialties. Meanwhile, the surgeries done by elderly surgeons also
had a lower reoperation rate, as compared with younger surgeons.
These imply that pelvic reconstructive surgery was more
technique-demanding and experience-dependent. Both variables
indicate the importance of training courses and experience accu-
mulation. It is in concordance with the Long et al26 report on the
analysis of patient characteristics to identify the predictors of sur-
gical failure after transvaginal mesh. Surgical experience
(p ¼ 0.043) was one of the two signiﬁcant predictors of surgical
failure, while other factors were not different, e.g., bodymass index,
POP stage, mesh type, and preoperative urinary symptoms and
urodynamic parameters (p > 0.05).26 Surgical-related outcomes
have also improved with increased experience in robotic-assisted
prolapse surgery, with an estimated learning curve of about
10e20 procedures.23 As for the choice of hysteropexy as a repeatuterine prolapse surgery in our study, all variables were not sig-
niﬁcant, including concomitant SUI surgery, patient age, surgeon
age, and hospital accreditation level.
As reported in our previous study,7 there has been a consid-
erable change in the surgical approach for uterine prolapse in
Taiwan over the past 11 years. It offers observational data of cases
of younger patients (< 50 years), with concomitant SUI surgery,
younger surgeons (< 50 years), male surgeons, regional or private
hospitals, where uterine-preserving procedures in treating uterine
prolapse were more likely to be performed.7 This study further
elucidates the variables for failed-primary-surgery-need-repeat
surgery, including hysteropexy, patient age, with concomitant SUI
surgery, and surgeon age. As for the choice of reoperation after
failed primary hysteropexy group, most preferred to receive hys-
terectomy, as compared to preserving the uterus. Frick et al28
reported that the doctor's opinion, risk of surgical complications,
and risk of malignancy were the most important factors in sur-
gical decision making in women seeking care for POP. To date,
there has been a paucity of high-quality data comparing
concomitant hysterectomy with/without colpopexy and hyster-
opexy with uterus preservation in uterine prolapse repair. Deter-
mining the best way to deal with uterine prolapse demands
continuous work in prospective controlled trials to guide patient
management decisions.6
There were several limitations in our study due to the inherent
retrospective observational nature. First, the exact procedures
performed were not speciﬁed, e.g., surgical routes, the use of syn-
thetic mesh, etc. Second, the possibility of miscoding existed due to
coding by medical administrative personnel instead of surgeons
themselves. Despite these limitations, our study offers population-
based nationwide observations on the choice of reoperation after
failed primary surgeries for uterine prolapse.
In conclusion, hysteropexy correlates with a higher reoperation
rate after failed primary surgeries for uterine prolapse. In addition
to surgical type, other variables, including concomitant SUI surgery,
patient age, and surgeon age also correlate with the reoperation
rate. Among the choice of repeat surgery after failed primary hys-
teropexy, most preferred hysterectomy; all the variables do not
correlate with the choice of repeat surgery among the failed hys-
teropexy group. However, the demand for a better hysteropexy
with uterine preservation from either patients or surgeons is
growing. The surgeon's training and practicing experience, pa-
tient's preference, and risk of surgical complications are all
important factors in surgical decision making. These ﬁndings
M.-P. Wu et al. / Gynecology and Minimally Invasive Therapy 4 (2015) 120e125 125should provide further impetus to investigate the efﬁcacy of
uterine-sparing procedures to help women make informed de-
cisions regarding prolapse surgery.Acknowledgments
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